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ABSTRACT: A molecular signal displayed on the external surface of one population of vesicles was used to trigger a catalytic process on the 
inside of a second population of vesicles. The key recognition event is the transfer of a protein (NeutrAvidin) bound to vesicles displaying 
desthiobiotin to vesicles displaying biotin. The desthiobiotin•protein complex was used to anchor a synthetic transducer in the outer leaflet of 
the vesicles, and when the protein was displaced, the transducer translocated across the bilayer to expose a catalytic head group to the internal 
vesicle solution. As a result, an ester substrate encapsulated on the inside of this second population of vesicles was hydrolysed to give a fluores-
cence output signal. The protein has four binding sites, which leads to multivalent interactions with membrane-anchored ligands and very high 
binding affinities. Thus biotin, which has a dissociation constant three orders of magnitude higher than desthiobiotin, did not displace the 
protein from the membrane-anchored transducer, and membrane-anchored biotin displayed on the surface of a second population of vesicles 
was required to generate an effective input signal. 
INTRODUCTION 
Cell membranes coordinate a large variety of biological processes 
by selectively recognizing and responding to different external stim-
uli, and membrane-spanning proteins play a vital role in these signal-
ing pathways. Direct mass transfer by carrier proteins or by channels 
allows exchange of molecules between the inside and outside of the 
cell.1 For signaling pathways that do not involve direct mass transfer, 
an external signal induces dimerization or conformational changes 
in membrane-spanning proteins that result in a cascade of reactions 
on the inner side of the membrane.2,3 Although numerous examples 
of synthetic membrane channels and transporters have been re-
ported,4-10 signal transduction without mass transfer is considerably 
more challenging.11-16  
We have recently reported a novel transmembrane signaling 
mechanism, which operates by controlled translocation of a syn-
thetic transducer across a vesicle lipid bilayer (Figure 1).17,18 The ex-
ternal recognition head group of the transducer becomes membrane 
permeable in response to an external chemical stimulus, which leads 
to membrane translocation, exposing a catalytic head group to the 
interior of the vesicle. Catalytic hydrolysis of an internal substrate 
generates an amplified output signal, which can also be used to trig-
ger release of the vesicle contents.19 The choice of recognition head 
group can be used to make this system respond to different external 
stimuli, such pH17 or metal ions.18 Here, we extend the scope of the 
signal transduction system by using ligand-protein binding as the in-
put signal. We show that multivalent interactions at lipid bilayer in-
terfaces lead to dramatic changes in protein-ligand binding affinities 
and exploit this phenomenon to achieve signal transduction pro-
cesses between two different populations of vesicles. 
 
Figure 1. Signal transduction via membrane translocation. The trans-
ducer has two switchable head groups. In the OFF state, the recognition 
head group is membrane impermeable and sits in the external aqueous 
phase (purple), and the internal pro-catalyst head group sits in the mem-
brane (red). An external signal switches the recognition head group to 
membrane permeable (blue), allowing translocation of the transducer 
across the bilayer. Binding of a charged cofactor to the catalytic head 
group (green) generates the ON state, where the catalyst turns over an 





Figure 2. a) An artificial signal transduction system that responds to protein-ligand binding. In the initial OFF state, the protein-transducer complex is 
anchored in the outer leaflet of the vesicle bilayer and the catalytic head group (red) is buried in the membrane. The input is a competing ligand (pink) 
that binds the protein (orange), displacing the transducer head group (blue) and allowing it to enter the membrane. Translocation followed by binding 
of a charged cofactor (Zn2+) from the internal aqueous solution of the vesicle activates the catalytic head group (green), which hydrolyses an internal 
substrate (grey) to generate an amplified output signal (yellow). b)  Molecular structure of transducer 1, the corresponding zinc complex, substrate 2, 
fluorescent hydrolysis product 3, and biotin. 
APPROACH 
The avidin-biotin system is a well-exploited and reliable biotech-
nology tool used in a broad range of applications such as biochemical 
assays,20 diagnosis,21 and affinity purification.22 Avidins are water sol-
uble proteins that have an extremely high affinity for biotin (Kd ~ 
0.01 pM) and a somewhat lower affinity for desthiobiotin (Kd ~ 10 
pM).23 The desthiobiotin-avidin-biotin system is ideally suited to 
construction of a transducer with a recognition head group that re-
sponds to biotin as a molecular input signal. The approach is illus-
trated in Figure 2a. Desthiobiotin is used as the recognition head 
group on transducer 1, and assembly of vesicles in the presence of 
avidin should lead to the OFF state, because the desthiobiotin-avi-
din complex is not membrane permeable. Addition of the higher af-
finity ligand, biotin (pink), to the external solution should displace 
the protein from the vesicles, allowing the relatively non-polar des-
thiobiotin to enter the membrane. Translocation of the transducer 
followed by binding of zinc ion cofactors to the internal catalytic 
head group will initiate hydrolysis of ester substrate 2 inside the ves-
icles. The output signal in the ON state is the fluorescent emission 
from the hydrolysis product 3. 
The molecular structure of transducer 1 is shown in Figure 2b. 
The hydrophobic steroid core provides the membrane anchor, and 
the pyridine oxime moiety is the pro-catalyst head group that will be 
activated by coordination to zinc ions.  The desthiobiotin recogni-
tion head group is attached via a PEG linker to make sure it can reach 
the avidin binding site without steric clashes between the protein 
and the membrane (see Supporting Information Fig. S1). We used 
NeutrAvidin as the protein component of this system, because it has 
a low isoelectric point (pI = 6.3), which minimizes protein aggrega-
tion at neutral pH. 
RESULTS AND DISCUSSION 
Synthesis 
Synthesis of ester substrate 2 was described previously.17 Trans-
ducer 1 was synthesized from lithocholic acid in four steps as shown 
in Scheme 1. Coupling of the alcohol with chloroacetyl chloride, 
followed by EDC coupling of the carboxylic acid with N-Boc-4,7,10-
trioxa-1,13-tridecanediamine 5 gave intermediate 6. Deprotection 
of the amine followed by EDC coupling with desthiobiotin 7 gave 8. 
Functionalization with pyridine dioxime 9 ligand gave transducer 1. 
 
Scheme 1. Synthesis of Desthiobiotin Transducer 1. 
A membrane-anchored biotin derivative was required for the sig-
naling experiments described below. Compound 10 was therefore 
synthesized from lithocholic acid using the route shown in Scheme 
2. The carboxylic acid group of lithocholic acid was converted to the 
corresponding amine in two steps, and then EDC coupling was used 


























































































Scheme 2. Synthesis of Biotin Derivative 10. 
Characterization of the Input Signal 
In order to confirm that NeutrAvidin binds transducer 1, a 4’-hy-
droxyazobenzene-2-carboxylic acid (HABA) binding assay was first 
conducted in solution. HABA has a UV absorption maximum at 348 
nm, which moves to 500 nm when it binds to NeutrAvidin.24 Figure 
3 shows the result of titrating a solution of transducer 1 in DMSO 
into a phosphate buffer solution of the HABA-NeutrAvidin complex 
at pH 7. The absorption at 500 nm decreased linearly with the 
amount of transducer until 4 equivalents had been added. Addition 
of just DMSO to the same solution had no effect on the absorption 
at 500 nm. This result indicates that, as expected, NeutrAvidin binds 
four equivalents of transducer 1 with a high affinity. Note that Neu-
trAvidin has four identical biotin binding sites, which will become 
important for understanding the signaling experiments below. 
 
Figure 3. UV/Vis absorption titration of transducer 1 in DMSO solu-
tion (filled circles) or just DMSO (open circles) into a mixture of 0.3 
mM HABA and 8 μM NeutrAvidin in 100 mM phosphate buffer with 
150 mM NaCl at pH 7. The UV/Vis absorption at 500 nm is plotted as 
a function of the ratio of transducer [1] to protein [NAv]. 
To confirm that NeutrAvidin also binds transducer 1 when it is 
embedded in a vesicle membrane, we used a Förster resonance en-
ergy transfer (FRET) assay. A NeutrAvidin-TexasRed conjugate is 
commercially available, and nitrobenzoxadiazole (NBD) is a 
complementary dye suitable for FRET experiments. We prepared 
one set of phosphatidylcholine vesicles loaded with transducer 1 and 
a C6-Ceramide derivative of NBD and another set of vesicles loaded 
with only the dye. The NeutrAvidin-TexasRed conjugate was added 
to both sets of vesicles, and the results are shown in Figure 4. For the 
vesicles that did not contain transducer 1, no change in the NBD flu-
orescence was observed, which indicates that the protein does not 
bind to the vesicles (Figure 4a). In contrast, when transducer 1 was 
also present in the vesicles, addition of NeutrAvidin-TexasRed re-
sulted in quenching of the NBD fluorescence. The transducer-de-
pendent quenching indicates that the protein does indeed bind to 
the membrane-anchored transducer, and that this interaction brings 
to the two dyes into sufficiently close proximity for FRET (Figure 
4b). These results suggest that the NeutrAvidin•1 complex should 
provide a usable OFF state for signal transduction experiments. 
NeutrAvidin makes a 1:4 complex with 1, so there are four mem-
brane-anchors exposed on the surface of complex, and there is po-
tential for the complex to cross-link vesicles. Careful control of stoi-
chiometry was therefore required. For example, for the experiment 
shown in Figure 4, an excess of protein was used, and no vesicle ag-
gregation was observed. 
 
Figure 4. Fluorescence spectra (excitation at 330 nm, emission at 540 
nm) of 0.01 mM 200 nm POPC vesicles with 2.5 mol% loading of NBD 
C6-Ceramide containing 25 mM HEPES buffer 150 mM NaCl at pH 7: 
a) without transducer 1, and b) with 5 mol% loading of transducer 1. 
Black: initial emission spectra, blue: spectra after addition of 0.5 μM 
NeutrAvidin-TexasRed (1 eq. relative to 1). Schematic illustrations are 
shown in c) and d), respectively. 
The same FRET assay was used to test the effect of biotin on the 
interaction between NeutrAvidin and transducer 1. Vesicles loaded 
with transducer 1 and NBD C6-Ceramide were prepared, and the 
NeutrAvidin-TexasRed conjugate was added. The fluorescence 
quenching described above was observed, which confirms that the 
protein binds to the membrane-anchored transducer on the surface 
of the vesicles. Then biotin was added, but no change in fluorescence 
was observed (Figure 5a). If biotin were to dissociate NeutrAvidin 
from the vesicles, then the FRET between TexasRed and NBD 
would be abolished, which suggests that membrane-anchored des-
thiobiotin outcompetes biotin for protein binding. In solution, bio-
tin binds NeutrAvidin with a 1,000-fold higher affinity than desthio-
biotin. A possible reason for the change in relative affinity in the case 
of membrane-anchored ligands is that NeutrAvidin has four binding 






















































multivalent interactions are possible. The protein has two binding 
sites on one face and two on the opposite face, so we suggest that two 
desthiobiotin moieties bind cooperatively to two protein binding 
sites at the vesicle surface, leading to an enhanced binding affinity for 
membrane-anchored desthiobiotin relative to solution-phase biotin 
(Figure 5c).25,26 
 
Figure 5. Fluorescence spectra (excitation at 330 nm, emission at 540 
nm) of 0.01 mM 200 nm POPC vesicles with 2.5 mol% NBD C6-
Ceramide and 5 mol% transducer 1 containing 25 mM HEPES buffer 
150 mM NaCl at pH 7: a) initial spectrum (black), spectrum after addi-
tion of 0.5 μM NeutrAvidin-TexasRed (1 eq. relative to 1) (blue), and 
spectrum after subsequent addition of 2 μM biotin (4 eq. relative to Neu-
traAvidin-TexasRed) (green), and b) initial spectrum (black), spectrum 
after addition of 0.5 μM NeutrAvidin-TexasRed (1 eq. relative to 1) 
(blue), and spectrum after subsequent addition of vesicles with 5 mol% 
biotin derivative 10 to reach a bulk concentration of 2 μM 10 (4 eq. rel-
ative to NeutraAvidin-TexasRed) (red). Schematic illustrations are 
shown in c) and d), respectively. 
If anchoring desthiobiotin in a membrane increases the apparent 
binding affinity for NeutrAvidin, the same should be true of biotin. 
To test this hypothesis, we used vesicles loaded with membrane-an-
chored biotin as the input signal to displace NeutrAvidin from the 
transducer. The FRET experiment described above was repeated, 
but instead of adding biotin to displace the NeutrAvidin from the 
membrane-anchored transducer, vesicles loaded with 5 mol% of bi-
otin derivative 10 were added. The results are shown in Figure 5b. In 
this case, the fluorescence of the NBD present in the transducer-
loaded vesicles was restored. This result shows that vesicles contain-
ing biotin derivative 10 remove NeutrAvidin from vesicles contain-
ing transducer 1. In other words, multivalent biotin vesicles outcom-
pete multivalent desthiobiotin vesicles, as expected from the solu-
tion-phase binding affinities. The fact that 10 binds NeutrAvidin 
without the PEG linker used in 1 suggests that a linker is not required 
for protein binding at the membrane interface. However, Figure 5b 
shows that the fluorescence is not fully restored by the biotin vesi-
cles, which could be due to a relatively small difference in the protein 
binding affinities of the two vesicle-anchored ligands. 
In these experiments, the protein was present in excess relative to 
1 to avoid cross-linking of the vesicles, so the other protein binding 
sites were initially empty. Addition of the biotin vesicles could cause 
cross-linking due to multivalent interactions at both vesicle mem-
brane interfaces, but an excess of biotin was used relative to trans-
ducer 1, and no aggregation was observed on the timescale of the 
measurements. The reorganization of multivalent interactions that 
would lead to vesicle aggregation appears to be relatively slow. How-
ever, when solutions containing both sets of vesicles were stored 
overnight, visible flocculation was observed indicating that aggrega-
tion of this system does take place on longer timescales. 
Transmembrane Signaling Experiments 
Before carrying out signaling experiments, we tested the catalytic 
activity of the transducer in the ON and the OFF states. Vesicles 
were prepared containing 250 μM ester 2 and 250 μM zinc chloride 
in HEPES buffer at pH 7. When transducer 1 was added to this solu-
tion, it inserted into the membrane and initiated catalysis of ester hy-
drolysis inside the vesicles (green data in Figure 6a). This system 
corresponds to the ON state of the signal transduction system and 
shows that the desthiobiotin head group does not interfere with ca-
talysis. When the NeutrAvidin•1 complex was added to the vesicle 
solution, no increase in the background rate of hydrolysis of sub-
strate 2 inside the vesicles was observed (black data in Figure 6a). 
This system corresponds to the OFF state of the signal transduction 
system and shows that protein binding holds the catalytic head 
group inside the membrane, preventing translocation. Vesicle cross-
linking in this OFF state was avoided by adding an excess of the Neu-
trAvidin•1 complex to ensure that the surfaces of the vesicles were 
saturated. 
 
Figure 6. a) Time dependence of the normalized fluorescence emission 
intensity at 510 nm (exciting at 415 nm). The ON state (green) was ob-
tained by adding transducer 1 in DMSO to vesicles to reach 10 mol% 
loading in lipids and a bulk concentration of 10 µM 1 (addition at time 
point indicated by the arrow). The OFF state (black) was obtained by 
adding the NeutrAvidin•1 complex (17 μM protein, 67 μM 1, i.e. 0.25 
eq. of protein eq. relative to 1). All experiments were conducted in 0.1 
mM 200 nm DOPC/DOPE vesicles containing 250 μM 2, 250 μM zinc 




Figure 7. a) Time dependence of the normalized fluorescence emission 
intensity at 510 nm (exciting at 415 nm). The ON state (green) was ob-
tained by adding transducer 1 in DMSO to vesicles to reach 10 mol% 
loading in lipids and a bulk concentration of 1 µM 1. After 100 minutes, 
2 μM NeutrAvidin was added (2 eq. relative to 1) to generate the OFF 
state (black, addition indicated by the arrow). All experiments were con-
ducted in 0.01 mM 200 nm DOPC/DOPE vesicles containing 250 μM 
2, 250 μM zinc chloride, and 25 mM HEPES buffer 150 mM NaCl at pH 
7. b) Schematic illustration. 
Having demonstrated that the ON and OFF states function as an-
ticipated, we then attempted to switch between these two states by 
using external signals to initiate signal transduction. The ON state 
was assembled as described above, and NeutrAvidin was added to 
the vesicle suspension after two hours. Figure 7a shows that addition 
of the protein efficiently switches the system from the ON to the 
OFF state. In this case, two equivalents of protein relative to trans-
ducer 1 were used to avoid vesicle cross-linking, and this stoichiom-
etry is more effective at suppressing the reaction than the 0.25 equiv-
alents of NeutrAvidin used for the experiments shown in Figure 6a. 
To demonstrate switching from the OFF to the ON state, the 
OFF state was assembled as described above by adding the Neu-
trAvidin•1 complex to vesicles containing substrate 2 and zinc ions. 
Figure 8a shows the effect of adding biotin to this system. Biotin 
slightly reduced the background rate of substrate hydrolysis (red 
data), but did not generate an ON state, as expected from the FRET 
experiments described above. Even a saturated solution of 1 mM bi-
otin produced no signs of an ON signal (purple data). However, ad-
dition of vesicles loaded with 10 mol% of biotin derivative 10 lead to 
a rapid increase in fluorescence emission characteristic of the ON 
state (green data in Figure 8a). When the loading of 10 in the biotin 
vesicles was lowered to 5 mol%, an ON state was also obtained, albeit 
with lower catalyst activity (blue data). This result suggests that the 
affinity of the biotin vesicles for NeutrAvidin can be controlled with 
vesicle loading by changing the effective molarity for the cooperative 
binding interactions at the membrane interface. The timescale for 
the signaling experiments is significantly longer than for the FRET 
experiments, so flocculation was sometimes observed at the end of 
these experiments, presumably due to vesicle cross-linking. The ex-
periments shown in Figure 8 indicate that signaling molecules dis-
played on the surface of one set of vesicles are able to initiate catalytic 
substrate turnover inside a second set of different vesicles. This 
process is reminiscent of the kind of complex cell-to-cell signaling 
processes found in biological organisms. 
 
Figure 8. a) Time dependence of the normalized fluorescence emission 
intensity at 510 nm (exciting at 415 nm). The OFF state (black) was 
obtained by adding NeutrAvidin•1 complex (17 μM protein, 67 μM 1, 
i.e. 0.25 eq. of protein eq. relative to 1) to 0.1 mM DOPC/DOPE vesi-
cles  containing 250 μM 2, 250 μM zinc chloride, and 25 mM HEPES 
buffer 150 mM NaCl at pH 7. Addition to the OFF vesicle solution of 
either 67 μM biotin (4 eq. relative to NeutrAvidin, red) or 1 mM biotin 
(60 eq. relative to NeutrAvidin, purple) biotin both gave OFF states. Ad-
dition to the OFF vesicle solution of different amounts of 200 nm 
DOPC/DOPE vesicles loaded with 10 mol% of biotin derivative 10 
(green) or 5 mol% of biotin derivative 10 (blue) to reach bulk concen-
trations of 67 μM 10 (4 eq. relative to NeutrAvidin) both gave ON 
states. b) Schematic illustration. 
 
CONCLUSIONS 
The system described here constitutes the first example of a syn-
thetic construct where cooperative interactions at membrane inter-
faces have been used to trigger transmembrane signal transduction. 
A molecular signal (biotin) displayed on the external surface of one 
population of vesicles was used to trigger a catalytic process on the 
inside of a second population of vesicles. The key recognition event 
is the exchange of proteins (NeutrAvidin) bound to vesicles display-
ing desthiobiotin to vesicles displaying biotin. The desthiobi-
otin•NeutrAvidin complex was used to anchor a synthetic trans-
ducer in the outer leaflet of the vesicles, and when the protein was 
displaced, the transducer translocated across the bilayer to expose a 
catalytic head group to the internal vesicle solution. As a result, an 
ester substrate encapsulated on the inside of this second population 
of vesicles was hydrolysed to give a fluorescent product, which 
 
constitutes an amplified output signal. NeutrAvidin has four ligand 
binding sites, and multivalent interactions with the membrane-an-
chored ligands leads to very high binding affinities. Thus biotin, 
which has a dissociation constant three orders of magnitude higher 
than desthiobiotin, did not displace NeutrAvidin from the mem-
brane-anchored transducer, and membrane-anchored biotin was re-
quired to generate the input signal. These findings extend the scope 
of artificial signal transduction from purely synthetic assemblies into 
more sophisticated systems, which opens up the potential for future 
development of intelligent responsive vesicles in bionanotechnol-
ogy. 
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